Skip to main content
Signal8

FOXO TECHNOLOGIES INC. (FOXO)

FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Care Facilities

FOXO Technologies Inc. logo

FOXO Technologies Inc.

OTC:FOXOHealthcare
+0.00%$0.1000
Mkt Cap$166K
Float1.66M
O/S1.66M
Inst Own-
SI0.2%
Dilution
FormDescription
DEF 14C
Definitive Information Statement
7
PRE 14C
SEC Filing
8
10-Q
8-K
5.07
5
8-K
7.01,9.01
4
8-K
8-K
7.01,9.01
3
8-K
5.03,7.01,9.01
3
DEF 14C
Definitive Information Statement
5
8-K
8-K
PRE 14C
SEC Filing
8-K
10-Q
8-K
5.03,9.01
10-K
Annual Report
DEF 14C
Definitive Information Statement
8-K
5.07
PRE 14C
SEC Filing
NT 10-K
SEC Filing
8-K
5.02
EFFECT
Notice of Effectiveness
424B3
Prospectus
S-1
Registration Statement
8-K
1.01,3.02,9.01

1-25 of 535

…
    FOXO TECHNOLOGIES INC. (FOXO) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8